The acquisition of Tornado Spectral Systems is likely to have a positive short-term impact on Bruker's stock as it expands the company's product offerings in the biopharma sector, a field with significant growth potential. The addition of Tornado's advanced Raman technology and products could improve Bruker's competitive edge and market share, which investors may view favorably. However, without financial terms disclosed, the exact impact on financials remains uncertain.